Search research articles
Contact Us
Filters
Showing results (11-20 of 19) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 19 results.
Atherosclerosis
|
February 18, 2014
Chronic kidney disease on hemodialysis is associated with decreased serum PCSK9 levels
H Abujrad, J Mayne, M Ruzicka, et al.
Osteoarthritis and Cartilage
|
August 9, 2015
Impact of patient decision aids on appropriate and timely access to hip or knee arthroplasty for osteoarthritis: a randomized controlled trial
D Stacey, M Taljaard, G Dervin, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
April 11, 2015
Relationship between testosterone, estradiol and circulating PCSK9: Cross-sectional and interventional studies in humans
T C Ooi, A Raymond, M Cousins, et al.
Current Oncology (Toronto, Ont.)
|
July 10, 2019
Testing e-mail content to encourage physicians to access an audit and feedback tool: a factorial randomized experiment
G Vaisson, H O Witteman, S Chipenda-Dansokho, et al.
BMJ (Clinical Research Ed.)
|
September 28, 2011
Impact of CONSORT extension for cluster randomised trials on quality of reporting and study methodology: review of random sample of 300 trials, 2000-8
N M Ivers, M Taljaard, S Dixon, et al.
Public Health
|
June 16, 2026
Changes in the proximity of alcohol outlets to schools after the introduction of convenience store alcohol sales in Ontario, Canada: A descriptive study
E L Friesen, R MacDonald-Spracklin, M Taljaard, et al.
Implementation Science : IS
|
October 23, 2015
Protocol for the development of a CONSORT-equity guideline to improve reporting of health equity in randomized trials
Vivian Welch, J Jull, J Petkovic, et al.
BMJ Open
|
September 28, 2017
When is a randomised controlled trial health equity relevant? Development and validation of a conceptual framework
J Jull, M Whitehead, M Petticrew, et al.
Clinical Pharmacology and Therapeutics
|
November 8, 2012
Impact of the CYP4F2 p.V433M polymorphism on coumarin dose requirement: systematic review and meta-analysis
E Danese, M Montagnana, J A Johnson, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 19) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 19 results.
Atherosclerosis
|
February 18, 2014
Chronic kidney disease on hemodialysis is associated with decreased serum PCSK9 levels
H Abujrad, J Mayne, M Ruzicka, et al.
Osteoarthritis and Cartilage
|
August 9, 2015
Impact of patient decision aids on appropriate and timely access to hip or knee arthroplasty for osteoarthritis: a randomized controlled trial
D Stacey, M Taljaard, G Dervin, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
April 11, 2015
Relationship between testosterone, estradiol and circulating PCSK9: Cross-sectional and interventional studies in humans
T C Ooi, A Raymond, M Cousins, et al.
Current Oncology (Toronto, Ont.)
|
July 10, 2019
Testing e-mail content to encourage physicians to access an audit and feedback tool: a factorial randomized experiment
G Vaisson, H O Witteman, S Chipenda-Dansokho, et al.
BMJ (Clinical Research Ed.)
|
September 28, 2011
Impact of CONSORT extension for cluster randomised trials on quality of reporting and study methodology: review of random sample of 300 trials, 2000-8
N M Ivers, M Taljaard, S Dixon, et al.
Public Health
|
June 16, 2026
Changes in the proximity of alcohol outlets to schools after the introduction of convenience store alcohol sales in Ontario, Canada: A descriptive study
E L Friesen, R MacDonald-Spracklin, M Taljaard, et al.
Implementation Science : IS
|
October 23, 2015
Protocol for the development of a CONSORT-equity guideline to improve reporting of health equity in randomized trials
Vivian Welch, J Jull, J Petkovic, et al.
BMJ Open
|
September 28, 2017
When is a randomised controlled trial health equity relevant? Development and validation of a conceptual framework
J Jull, M Whitehead, M Petticrew, et al.
Clinical Pharmacology and Therapeutics
|
November 8, 2012
Impact of the CYP4F2 p.V433M polymorphism on coumarin dose requirement: systematic review and meta-analysis
E Danese, M Montagnana, J A Johnson, et al.
Page
of 2